Author:
Borghetti A.,Baldin G.,Ciccullo A.,Gagliardini R.,D'Avino A.,Mondi A.,Ciccarelli N.,Lamonica S.,Fanti I.,Trecarichi E.,Fabbiani M.,Cauda R.,De Luca A.,Di Giambenedetto S.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference7 articles.
1. Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients
2. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
3. Brief Report
4. Katlama C , Soulié C , Blanc C et al . Dolutegravir monotherapy in HIV-infected patients with suppressed HIV viremia. In: Abstracts of the Fifteenth European AIDS Conference, Barcelona, 2015. Oral Abstract PS4/4.
5. Figueroa MI , Sued O , Patterson P et al . Dolutegravir-lamivudine as initial therapy in HIV-infected, ARV naïve patients: first results of the PADDLE trial. In: Abstracts of the Fifteenth European AIDS Conference, Barcelona, 2015. Oral Abstract LBPS4/1.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献